Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Bar Harbor Bankshares
BHB
$681M
| $2.68M | ﹤0.01% |
103,656
-11,340
| -10% | -$300K |
|
1977
Nexa Resources
NEXA
$1.93B
| $2.68M | ﹤0.01% |
445,400
-57,300
| -11% | -$487K |
|
|
PHLT
1978
DELISTED
Performant Healthcare Inc
PHLT
| $2.68M | ﹤0.01% |
1,017,642
-214,949
| -17% | -$534K |
|
1979
Mesa Laboratories
MLAB
$631M
| $2.67M | ﹤0.01% |
13,100
| – | – |
|
|
RIDE
1980
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $2.67M | ﹤0.01% |
112,635
+53,426
| +90% | +$1.72M |
|
|
FARM
1981
DELISTED
Farmer Brothers
FARM
| $2.67M | ﹤0.01% |
568,900
-15,348
| -3% | -$86.6K |
|
1982
iShares MSCI China ETF
MCHI
$6.14B
| $2.67M | ﹤0.01% |
+47,800
| New | +$2.45M |
|
1983
Arlo Technologies
ARLO
$1.5B
| $2.67M | ﹤0.01% |
425,200
-80,800
| -16% | -$591K |
|
|
MAG
1984
DELISTED
MAG Silver
MAG
| $2.67M | ﹤0.01% |
218,900
+171,100
| +358% | +$2.5M |
|
1985
CytomX Therapeutics
CTMX
$760M
| $2.66M | ﹤0.01% |
1,454,261
+558,361
| +62% | +$1.07M |
|
1986
Kura Oncology
KURA
$882M
| $2.66M | ﹤0.01% |
145,000
-133,400
| -48% | -$1.92M |
|
|
SPNE
1987
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.65M | ﹤0.01% |
469,000
+83,200
| +22% | +$725K |
|
1988
Identive
INVE
$63.4M
| $2.65M | ﹤0.01% |
228,752
+122,900
| +116% | +$1.54M |
|
|
CTIC
1989
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.65M | ﹤0.01% |
443,613
-667,800
| -60% | -$3.42M |
|
|
XHR
1990
Xenia Hotels & Resorts
XHR
$1.73B
| $2.64M | ﹤0.01% |
181,700
+83,300
| +85% | +$1.48M |
|
1991
Personalis
PSNL
$1.54B
| $2.64M | ﹤0.01% |
764,811
+672,400
| +728% | +$3.42M |
|
|
RADI
1992
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $2.64M | ﹤0.01% |
172,800
+91,100
| +112% | +$1.31M |
|
|
MRSN
1993
DELISTED
Mersana Therapeutics
MRSN
| $2.63M | ﹤0.01% |
22,813
-13,955
| -38% | -$1.31M |
|
1994
AZZ Inc
AZZ
$4.55B
| $2.63M | ﹤0.01% |
64,500
+59,600
| +1,216% | +$2.68M |
|
1995
Patria Investments
PAX
$1.79B
| $2.63M | ﹤0.01% |
199,200
+70,900
| +55% | +$1.12M |
|
1996
Marchex
MCHX
$77.5M
| $2.62M | ﹤0.01% |
1,987,898
-29,266
| -1% | -$54.9K |
|
|
BORR
1997
Borr Drilling
BORR
$1.25B
| $2.62M | ﹤0.01% |
569,453
-490,158
| -46% | -$2.43M |
|
1998
Lantronix
LTRX
$275M
| $2.62M | ﹤0.01% |
486,194
-20,600
| -4% | -$119K |
|
1999
Haemonetics
HAE
$4.16B
| $2.61M | ﹤0.01% |
40,100
+18,000
| +81% | +$1.07M |
|
2000
OSI Systems
OSIS
$3.82B
| $2.61M | ﹤0.01% |
30,600
-3,400
| -10% | -$279K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.